04/02/2024
3:56 PM | Elite Pharmaceuticals (Issuer)
Hakim Nasrat A (Reporting)
| Form 4/A | |
04/02/2024
3:58 PM | Elite Pharmaceuticals (Issuer)
Hakim Nasrat A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:06 PM | Elite Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/28/2024
3:06 PM | Elite Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024
3:55 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
1:21 PM | Elite Pharmaceuticals (Issuer)
Hakim Nasrat A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
3:20 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
3:20 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2023
5:58 PM | Caskey Davis S (Reporting)
Elite Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
6:05 PM | Elite Pharmaceuticals (Issuer)
WHITNELL JEFFREY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:50 PM | Dash Barry H (Reporting)
Elite Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
3:15 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
3:05 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
4:30 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
3:20 PM | Elite Pharmaceuticals (Filer)
| Form 10-K/A | |
07/17/2023
3:15 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
4:15 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
3:43 PM | Elite Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
06/26/2023
11:46 AM | Elite Pharmaceuticals (Issuer)
Plassche Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2023
2:13 PM | Elite Pharmaceuticals (Issuer)
Pellegrino Mark N (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
